Rasa Vilimas

817 total citations
11 papers, 244 citations indexed

About

Rasa Vilimas is a scholar working on Oncology, Molecular Biology and Rheumatology. According to data from OpenAlex, Rasa Vilimas has authored 11 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 2 papers in Rheumatology. Recurrent topics in Rasa Vilimas's work include PARP inhibition in cancer therapy (4 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). Rasa Vilimas is often cited by papers focused on PARP inhibition in cancer therapy (4 papers), Lung Cancer Research Studies (4 papers) and Cancer therapeutics and mechanisms (2 papers). Rasa Vilimas collaborates with scholars based in United States, Japan and United Kingdom. Rasa Vilimas's co-authors include Geraldine O’Sullivan Coyne, Alice P. Chen, Sandra A. Mitchell, Lee J. Helman, T. Khanh, Lamin Juwara, Robert Meehan, Shivaani Kummar, Yvonne Horneffer and Paul S. Meltzer and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Rasa Vilimas

11 papers receiving 243 citations

Peers

Rasa Vilimas

ONCOL

RHEUM

PRM

PFM

Aurélie Houlier France

Shunsaku Yamamoto Japan

R Egido Spain

Kyu‐Young Oh South Korea

Marta Ježová Czechia

Alessandra Merlini Italy

Martina Tufano Italy

Laura Suárez–Fernández Spain

D. Zachar France

Allan Schuss United States

Aurélie Houlier France

Rasa Vilimas

117 ×1.0

ONCOL

152 ×1.6

21 ×0.3

RHEUM

58 ×0.9

PRM

72 ×1.5

PFM

Citations per year, relative to Rasa Vilimas Rasa Vilimas (= 1×) peers Aurélie Houlier

Countries citing papers authored by Rasa Vilimas

Since Specialization

Citations

This map shows the geographic impact of Rasa Vilimas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rasa Vilimas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rasa Vilimas more than expected).

Fields of papers citing papers by Rasa Vilimas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rasa Vilimas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rasa Vilimas. The network helps show where Rasa Vilimas may publish in the future.

Co-authorship network of co-authors of Rasa Vilimas

This figure shows the co-authorship network connecting the top 25 collaborators of Rasa Vilimas. A scholar is included among the top collaborators of Rasa Vilimas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rasa Vilimas. Rasa Vilimas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Takahashi, Nobuyuki, Lőrinc Sándor Pongor, Vinodh N. Rajapakse, et al.. (2025). Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor. Genome Medicine. 17(1). 15–15. 2 indexed citations

Desai, Parth, Nobuyuki Takahashi, Samantha Nichols, et al.. (2024). Tazemetostat in combination with topotecan and pembrolizumab in patients with recurrent small cell lung cancer.. Journal of Clinical Oncology. 42(16_suppl). TPS8130–TPS8130. 5 indexed citations

Connolly, Roisín M., Ciara C. O’Sullivan, Vamsidhar Velcheti, et al.. (2023). A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors. The Oncologist. 28(5). 460–e298. 5 indexed citations

Abel, Melissa L., Parth Desai, Christophe E. Redon, et al.. (2023). Abstract CT268: Targeting replication stress and chemotherapy resistance with a combination of sacituzumab govitecan and berzosertib: A phase I clinical trial. Cancer Research. 83(8_Supplement). CT268–CT268. 3 indexed citations

Lissa, Delphine, Nobuyuki Takahashi, Parth Desai, et al.. (2022). Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models. Nature Communications. 13(1). 2023–2023. 60 indexed citations

Desmond, Daniel, Rasa Vilimas, Éva Szabó, et al.. (2022). Durvalumab (D) in combination with olaparib (O) for advanced, previously treated non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. 40(16_suppl). e21153–e21153. 3 indexed citations

Falchook, Gerald S., Johanna C. Bendell, Susanna V. Ulahannan, et al.. (2020). Pen-866, a miniature drug conjugate of a heat shock protein 90 (HSP90) ligand linked to SN38 for patients with advanced solid malignancies: Phase I and expansion cohort results.. Journal of Clinical Oncology. 38(15_suppl). 3515–3515. 19 indexed citations

Bendell, Johanna C., Sanchayita Sen, Nenad Sarapa, et al.. (2019). First in human phase I/IIa study of PEN-866, a heat shock protein 90 (HSP90) ligand – SN38 conjugate for patients with advanced solid tumours: Phase I results. Annals of Oncology. 30. v172–v173. 7 indexed citations

Kummar, Shivaani, Geraldine O’Sullivan Coyne, T. Khanh, et al.. (2017). Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis). Journal of Clinical Oncology. 35(14). 1561–1569. 136 indexed citations

10.

Meehan, Robert, Alice P. Chen, Geraldine O’Sullivan Coyne, et al.. (2017). Abstract 4678: Pilot trial of talazoparib (BMN 673), an oral PARP inhibitor, in patients with advanced solid tumors carrying deleterious BRCA mutations. Cancer Research. 77(13_Supplement). 4678–4678. 1 indexed citations

11.

Coyne, Geraldine O’Sullivan, Shivaani Kummar, Peter L. Choyke, et al.. (2016). Activity of PF-03084014 in adults with desmoid tumors/aggressive fibromatosis.. Journal of Clinical Oncology. 34(15_suppl). 11028–11028. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact